The file's text, extracted by GovTribe without its formatting.
EXHIBIT D, ATTACHMENT NO. 7
How ____________________ Meets the Requirements of 10 CFR 707.5
| (print name of subcontractor) |
| 10 CFR 707.5 Subparagraph | |
| Summarized Requirement | |
| Citation | |
| (a) (1) |
| Prohibition of the use, possession, sale, distribution, or manufacture of illegal drugs at sites owned or controlled by DOE |
| (a) (2) |
| Plans for instruction of supervisors and employees concerning problems of substance abuse, including illegal drug use, and the availability of assistance through an employee assistance program and referrals to other resources, and the penalties that may be imposed upon employees for drug-related violations occurring on a DOE owned or controlled site. |
| (a) (3) |
| Provisions for distribution of a statement to employees engaged in the performance of a contract on a DOE owned or controlled site. This statement must set forth the contractor’s policies prohibiting the possession, sale, distribution, or manufacture of illegal drugs at the DOE owned or controlled site, and notification to the employee that as a condition of employment the employee will abide by the terms of the statement and notify the employer in writing of a conviction under a criminal drug statute for a violation occurring on the DOE owned or controlled site no later than 10 calendar days after such conviction. |
| (a) (4) |
| Subcontractor to notify the Procurement Representative of an employee’s conviction for a drug violation on a DOE-related site |
| (a) (5) |
| Provisions for disciplining employees (up to and including termination) OR for offering rehabilitation for such convictions |
| (a) (6) |
| Commitment to make a good faith effort to maintain a workplace free of substance abuse |
| (b) (1) |
| Notification to Contractor of positions subject to drug testing |
| N/A |
| (b) (2) |
| Prohibition of employees in Testing Designated Positions (TDP) from working in those positions when not free from the use of illegal drugs |
| (b) (3) |
| Sanctions for individuals in TDP who violate these prohibitions |
| (b) (4) (i) |
| Notification to those individuals subject to drug testing least 60 days in advance of initiating testing, unless the contractor is currently conducting a testing program. |
| (b) (4) (ii) |
| Urine drug testing of applicants for TDPs before final selection for employment or assignment |
| (b) (4) (iii) |
| Random urine drug testing for employees in TDPs |
| (b) (4) (iv) |
| Urine drug testing for employees in TDPs based on reasonable suspicion, as a result of an occurrence, or as a follow-up to rehabilitation |
| (b) (4) (v) |
| Testing employees with unescorted access to the control areas of certain DOE reactors based on reasonable suspicion or as a result of an occurrence |
| N/A @ MSTS |
| (b) (4) (vi) |
| Written notice to company from an employee in a TDP of drug-related arrest or conviction, or receipt of a positive drug test result within 10 calendar days of such arrest, conviction, or receipt. |
| (b) (4) (vii) |
| Appropriate action to be taken regarding an employee who is arrested for or convicted of a drug-related offense or has a positive drug test result |
| (b) (5) |
| Provisions to employees of the opportunity for rehabilitation, consistent with company policies |
| (b) (6) |
| Notification to Contractor’s Procurement Representative whenever a security concern is raised related to drugs |
Completed by:
Print Name & Title Signature Date Your program needs include a note or line somewhere regarding “medical marijuana (although prescribed by a physician) cannot be recognized as a legal drug in the federal environment”.
| Exhibit D | Solicitation No.: 407261-SH-23 |
| Page 1 of 1 |
Department of Energy